Single-cell profiling of immunogenic cell death in melanoma reveals prognostic signatures and therapeutic targets
The ICDRS, incorporating MYO10, provides a robust prognostic tool for melanoma and highlights MYO10 as a potential therapeutic target for improving immune responses in melanoma therapy.
Authors
- Yiyang Han (ORCID: https://orcid.org/0009-0005-1616-4346)
- Tao Jiang (ORCID: https://orcid.org/0000-0003-3833-4498)
- Chunsheng Yang
- Jingwen Huang
Institutions
- Xuzhou Medical College (CN)
- Second People’s Hospital of Huai’an (CN)
- University of Southampton (GB)
Publication Details
- Journal
- Discover Oncology
- Published
- 2026-01-16
- DOI
- https://doi.org/10.1007/s12672-026-04406-5
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00